| 1 |
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al. · The Lancet Neurology
Open access |
21 Dec 2017 |
8,265 |
| 2 |
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow, Elı́as Campo, Stefano Aldo Pileri et al. · Blood
Open access |
15 Mar 2016 |
7,935 |
| 3 |
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine
Open access |
11 May 2011 |
7,927 |
| 4 |
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al. · New England Journal of Medicine
Open access |
13 May 2020 |
7,547 |
| 5 |
ILAE Official Report: A practical clinical definition of epilepsy
Robert S. Fisher, Carlos Alberto Acevedo, Alexis A. Arzimanoglou et al. · Epilepsia
Open access |
Apr 2014 |
6,110 |
| 6 |
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine
Open access |
24 Jan 2002 |
5,630 |
| 7 |
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Pietro Lampertico, Kosh Agarwal, Thomas Berg et al. · Journal of Hepatology
|
18 Apr 2017 |
5,528 |
| 8 |
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Patrick Kwan, Alexis A. Arzimanoglou, Anne T. Berg et al. · Epilepsia
|
3 Nov 2009 |
4,888 |
| 9 |
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al. · New England Journal of Medicine
Open access |
18 May 2014 |
4,731 |
| 10 |
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al. · New England Journal of Medicine
|
5 Jun 2011 |
4,523 |
| 11 |
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al. · New England Journal of Medicine
Open access |
Dec 2018 |
4,157 |
| 12 |
Prone Positioning in Severe Acute Respiratory Distress Syndrome
Claude Guérin et al. · New England Journal of Medicine
Open access |
20 May 2013 |
4,142 |
| 13 |
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio et al. · Leukemia
Open access |
22 Jun 2022 |
4,010 |
| 14 |
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al. · The Lancet
Open access |
5 Dec 2016 |
3,732 |
| 15 |
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
Dec 2014 |
3,406 |
| 16 |
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al. · European Urology
Open access |
31 Aug 2016 |
3,282 |
| 17 |
DNA methylation-based classification of central nervous system tumours
David Capper et al. · Nature
Open access143 authors |
13 Mar 2018 |
3,228 |
| 18 |
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan et al. · New England Journal of Medicine
Open access |
19 Mar 2018 |
3,101 |
| 19 |
Vitamin D 3 and Calcium to Prevent Hip Fractures in Elderly Women
M C Chapuy, M Arlot, F. Duboeuf et al. · New England Journal of Medicine
Open access |
3 Dec 1992 |
2,969 |
| 20 |
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al. · Science
Open access752 authors |
24 Sep 2020 |
2,885 |
| 21 |
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine
Open access |
9 Feb 2011 |
2,877 |
| 22 |
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al. · European Urology
Open access |
7 Nov 2020 |
2,876 |
| 23 |
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Victoria Campuzano et al. · Science
|
8 Mar 1996 |
2,812 |
| 24 |
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Richard S. Hotchkiss, Guillaume Monneret, Didier M. Payen · Nature reviews. Immunology
ReviewOpen access |
15 Nov 2013 |
2,777 |
| 25 |
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al. · The Lancet Oncology
|
23 Mar 2015 |
2,696 |
| 26 |
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine
|
9 Feb 2011 |
2,567 |
| 27 |
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
Laurent Papazian, Jean-Marie Forel, Arnaud Gacouin et al. · New England Journal of Medicine
Open access |
15 Sep 2010 |
2,470 |
| 28 |
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
Thierry O. Philip, Cesare Guglielmi, Anton Hagenbeek et al. · New England Journal of Medicine
|
7 Dec 1995 |
2,458 |
| 29 |
ESUR prostate MR guidelines 2012
Jelle O. Barentsz, Jonathan Richenberg, Richard Clements et al. · European Radiology
Open access |
9 Feb 2012 |
2,452 |
| 30 |
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Kevin R. Flaherty, Athol Umfrey Wells, Vincent Cottin et al. · New England Journal of Medicine
Open access |
29 Sep 2019 |
2,440 |
| 31 |
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
J. P. Frat et al. · New England Journal of Medicine
Open access |
17 May 2015 |
2,419 |
| 32 |
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)
Jean‐Pascal Lefaucheur et al. · Clinical Neurophysiology
Open access |
31 Dec 2019 |
2,413 |
| 33 |
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa et al. · New England Journal of Medicine
Open access |
4 Jul 2018 |
2,386 |
| 34 |
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n et al. · New England Journal of Medicine
Open access |
28 Sep 2019 |
2,318 |
| 35 |
Strategies and challenges for the next generation of antibody–drug conjugates
Alain Beck, Liliane Goetsch, Charles Dumontet et al. · Nature Reviews Drug Discovery
Review |
17 Mar 2017 |
2,280 |
| 36 |
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Jeffrey S. Weber et al. · New England Journal of Medicine
Open access |
10 Sep 2017 |
2,249 |
| 37 |
Development and Validation of the International Knee Documentation Committee Subjective Knee Form
James J. Irrgang, Allen F. Anderson, Arthur L. Boland et al. · The American Journal of Sports Medicine
|
Sep 2001 |
2,193 |
| 38 |
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)
Jean‐Pascal Lefaucheur et al. · Clinical Neurophysiology
Open access |
5 Jun 2014 |
2,178 |
| 39 |
Factors of patellar instability: An anatomic radiographic study
H Dejour, Gilles Walch, Laurent Nové-Josserand et al. · Knee Surgery Sports Traumatology Arthroscopy
|
Mar 1994 |
2,058 |
| 40 |
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
You Li et al. · The Lancet
Open access121 authors |
May 2022 |
2,013 |
| 41 |
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force
Gabor Abellán van Kan, Yves Rolland, Sandrine Andrieu et al. · The journal of nutrition health & aging
Open access |
Dec 2009 |
2,013 |
| 42 |
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
Denis P. Fouque, Kamyar Kalantar‐Zadeh, Joel D. Kopple et al. · Kidney International
Open access |
19 Dec 2007 |
2,009 |
| 43 |
Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
Michael R. McClung, Piet Geusens, Paul D. Miller et al. · New England Journal of Medicine
Open access |
Feb 2001 |
1,931 |
| 44 |
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M.M. Eggermont et al. · New England Journal of Medicine
Open access |
15 Apr 2018 |
1,906 |
| 45 |
Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)
Jean‐Pascal Lefaucheur et al. · Clinical Neurophysiology
Open access |
28 Oct 2016 |
1,878 |
| 46 |
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Jean‐François Obadia et al. · New England Journal of Medicine
|
27 Aug 2018 |
1,797 |
| 47 |
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Li Yu, Shanqin Xu, Maria M. Mihaylova et al. · Cell Metabolism
Open access |
Apr 2011 |
1,787 |
| 48 |
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
Ann‐Lii Cheng, Shukui Qin, Masafumi Ikeda et al. · Journal of Hepatology
Open access |
11 Dec 2021 |
1,749 |
| 49 |
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman et al. · New England Journal of Medicine
Open access |
22 Jan 2014 |
1,706 |
| 50 |
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew Xiuxuan Zhu et al. · The Lancet Oncology
|
18 Jan 2019 |
1,680 |